MEDDYGFA GELLIGAER SURGERY
HEOL HEN YSGOL, GELLIGAER, HENGOED
HF 4
The percentage of patients with a current diagnosis of heart failure due to LVD who are currently treated with an ACE inhibitor or Angiotensin Receptor Blocker, who are additionally treated with a beta-blocker licensed for heart failure, or recorded as intolerant to or having a contraindication to beta-blockers.
| Indicator | Year | Numerator | Denominator | Ratio | Centile |
|---|---|---|---|---|---|
| HF 4 | 2010 | 12 | 12 | 100.0% | |
| HF 4 | 2011 | 16 | 18 | 88.9% | |
| HF 4 | 2012 | 16 | 17 | 94.1% | |
| HF 4 | 2013 | 19 | 19 | 100.0% | |
| HF004W | 2014 | 9 | 9 | 100.0% | |
| HF004 | 2015 | 19 | 19 | 100.0% |
